Furthermore, in vivo studies of neurodegeneration, like post-mortem studies of tau, have revealed close associations between the distribution of neurodegeneration and cognitive deficits found in patients with AD [3, 19–23]. This evidence concerns the gene MAPT and Alzheimer disease.